Literature DB >> 25920732

Diffusion tensor imaging of the nigrostriatal fibers in Parkinson's disease.

Yu Zhang1,2, I-Wei Wu1,2, Shannon Buckley1,2, Christopher S Coffey3, Eric Foster3, Susan Mendick4, John Seibyl4, Norbert Schuff1,2.   

Abstract

BACKGROUND: Parkinson's disease (PD) is histopathologically characterized by the loss of dopamine neurons in the substantia nigra pars compacta. The depletion of these neurons is thought to reduce the dopaminergic function of the nigrostriatal pathway, as well as the neural fibers that link the substantia nigra to the striatum (putamen and caudate), causing a dysregulation in striatal activity that ultimately leads to lack of movement control. Based on diffusion tensor imaging, visualizing this pathway and measuring alterations of the fiber integrity remain challenging. The objectives were to 1) develop a diffusion tensor tractography protocol for reliably tracking the nigrostriatal fibers on multicenter data; 2) test whether the integrities measured by diffusion tensor imaging of the nigrostriatal fibers are abnormal in PD; and 3) test whether abnormal integrities of the nigrostriatal fibers in PD patients are associated with the severity of motor disability and putaminal dopamine binding ratios.
METHODS: Diffusion tensor tractography was performed on 50 drug-naïve PD patients and 27 healthy control subjects from the international multicenter Parkinson's Progression Marker Initiative.
RESULTS: Tractography consistently detected the nigrostriatal fibers, yielding reliable diffusion measures. Fractional anisotropy, along with radial and axial diffusivity of the nigrostriatal tract, showed systematic abnormalities in patients. In addition, variations in fractional anisotropy and radial diffusivity of the nigrostriatal tract were associated with the degree of motor deficits in PD patients.
CONCLUSION: Taken together, the findings imply that the diffusion tensor imaging characteristic of the nigrostriatal tract is potentially an index for detecting and staging of early PD.
© 2015 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  MRI; Parkinson's disease; diffusion tensor imaging; diffusion tensor tractography; nigrostriatal pathway

Mesh:

Year:  2015        PMID: 25920732      PMCID: PMC4418199          DOI: 10.1002/mds.26251

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  38 in total

Review 1.  Fiber tracking: principles and strategies - a technical review.

Authors:  Susumu Mori; Peter C M van Zijl
Journal:  NMR Biomed       Date:  2002 Nov-Dec       Impact factor: 4.044

2.  High angular resolution diffusion imaging reveals intravoxel white matter fiber heterogeneity.

Authors:  David S Tuch; Timothy G Reese; Mette R Wiegell; Nikos Makris; John W Belliveau; Van J Wedeen
Journal:  Magn Reson Med       Date:  2002-10       Impact factor: 4.668

3.  3-D diffusion tensor axonal tracking shows distinct SMA and pre-SMA projections to the human striatum.

Authors:  Stéphane Lehéricy; Mathieu Ducros; Alexandre Krainik; Chantal Francois; Pierre-François Van de Moortele; Kamil Ugurbil; Dae-Shik Kim
Journal:  Cereb Cortex       Date:  2004-05-27       Impact factor: 5.357

4.  Diffusion tensor MR imaging of the human brain.

Authors:  C Pierpaoli; P Jezzard; P J Basser; A Barnett; G Di Chiro
Journal:  Radiology       Date:  1996-12       Impact factor: 11.105

5.  Parkinson's disease patients show reduced cortical-subcortical sensorimotor connectivity.

Authors:  Michael Sharman; Romain Valabregue; Vincent Perlbarg; Linda Marrakchi-Kacem; Marie Vidailhet; Habib Benali; Alexis Brice; Stephane Lehéricy
Journal:  Mov Disord       Date:  2012-11-09       Impact factor: 10.338

Review 6.  The functional anatomy of basal ganglia disorders.

Authors:  R L Albin; A B Young; J B Penney
Journal:  Trends Neurosci       Date:  1989-10       Impact factor: 13.837

7.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

Review 8.  Cell therapeutics in Parkinson's disease.

Authors:  Olle Lindvall; Anders Björklund
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

Review 9.  The Parkinson Progression Marker Initiative (PPMI).

Authors: 
Journal:  Prog Neurobiol       Date:  2011-09-14       Impact factor: 10.885

10.  Case control study of diffusion tensor imaging in Parkinson's disease.

Authors:  L-L Chan; H Rumpel; K Yap; E Lee; H-V Loo; G-L Ho; S Fook-Chong; Y Yuen; E-K Tan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-07-05       Impact factor: 10.154

View more
  41 in total

1.  Combining Diffusion Tensor Imaging and Susceptibility Weighted Imaging on the Substantia Nigra of 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine (MPTP)-induced Rhesus Monkey Model of Parkinson's Disease.

Authors:  Q Zhang; L Li; B Miao; H Niu
Journal:  West Indian Med J       Date:  2016-04-18       Impact factor: 0.171

Review 2.  Update on Molecular Imaging in Parkinson's Disease.

Authors:  Zhen-Yang Liu; Feng-Tao Liu; Chuan-Tao Zuo; James B Koprich; Jian Wang
Journal:  Neurosci Bull       Date:  2017-12-27       Impact factor: 5.203

3.  Predictive model of spread of Parkinson's pathology using network diffusion.

Authors:  S Pandya; Y Zeighami; B Freeze; M Dadar; D L Collins; A Dagher; A Raj
Journal:  Neuroimage       Date:  2019-03-06       Impact factor: 6.556

Review 4.  Magnetic resonance imaging for the diagnosis of Parkinson's disease.

Authors:  Beatrice Heim; Florian Krismer; Roberto De Marzi; Klaus Seppi
Journal:  J Neural Transm (Vienna)       Date:  2017-04-04       Impact factor: 3.575

Review 5.  Neuroimaging at 7 Tesla: a pictorial narrative review.

Authors:  Tomohisa Okada; Koji Fujimoto; Yasutaka Fushimi; Thai Akasaka; Dinh H D Thuy; Atsushi Shima; Nobukatsu Sawamoto; Naoya Oishi; Zhilin Zhang; Takeshi Funaki; Yuji Nakamoto; Toshiya Murai; Susumu Miyamoto; Ryosuke Takahashi; Tadashi Isa
Journal:  Quant Imaging Med Surg       Date:  2022-06

6.  White matter alterations in early Parkinson's disease: role of motor symptom lateralization.

Authors:  Laura Pelizzari; Sonia Di Tella; Maria M Laganà; Niels Bergsland; Federica Rossetto; Raffaello Nemni; Francesca Baglio
Journal:  Neurol Sci       Date:  2019-10-24       Impact factor: 3.307

7.  Dopaminergic Nigrostriatal Connectivity in Early Parkinson Disease: In Vivo Neuroimaging Study of 11C-DTBZ PET Combined with Correlational Tractography.

Authors:  Carlos A Sanchez-Catasus; Nicolaas I Bohnen; Fang-Cheng Yeh; Nicholas D'Cruz; Prabesh Kanel; Martijn L T M Müller
Journal:  J Nucl Med       Date:  2020-08-28       Impact factor: 10.057

8.  Nigral MRI features of asymptomatic welders.

Authors:  Eun-Young Lee; Michael R Flynn; Guangwei Du; Mechelle M Lewis; Michael Goldenberg; Lan Kong; Richard B Mailman; Young-Seoub Hong; Xuemei Huang
Journal:  Parkinsonism Relat Disord       Date:  2021-02-24       Impact factor: 4.891

Review 9.  Restoring lost nigrostriatal fibers in Parkinson's disease based on clinically-inspired design criteria.

Authors:  Wisberty J Gordián-Vélez; Dimple Chouhan; Rodrigo A España; H Isaac Chen; Jason A Burdick; John E Duda; D Kacy Cullen
Journal:  Brain Res Bull       Date:  2021-07-28       Impact factor: 3.715

10.  Parkinsonism reversed from treatment of pineal non-germinomatous germ cell tumor.

Authors:  Sydni M Cole; Sasmit Sarangi; David Einstein; Malgorzata McMasters; Ron Alterman; Jeffrey Bruce; Lauren Hertan; Helen A Shih; Eric T Wong
Journal:  Surg Neurol Int       Date:  2021-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.